4//SEC Filing
Harrison Seth Loring 4
Accession 0001415889-25-015698
CIK 0001623526other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:33 PM ET
Size
5.5 KB
Accession
0001415889-25-015698
Insider Transaction Report
Form 4
Harrison Seth Loring
Director10% Owner
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-03+29,747→ 29,747 totalExercise: $10.90Exp: 2035-06-02→ Common Stock (29,747 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earlier of: (i) June 3, 2026 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001404955
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:33 PM ET
- Size
- 5.5 KB